Vernesa Dizdar's picture
Vernesa
Dizdar
PhD Candidate
Visit Address: 
Haukeland universitetssykehus, Laboratoriebygget
5021 Bergen
Postal Address: 
Postboks 7804
5021 Bergen
Phone: 
+47 55 97 30 79
Download vCard
Journal articles
  • Hausken, Trygve; Dizdar, Vernesa; Hanevik, Kurt; Lærum, Ole Didrik; Gilja, Odd Helge; Hatlebakk, Jan G; Langeland, Nina. 2012. Duodenal mucosal lymphocyte subgroups in patients with persisting abdominal symptoms after Giardia lamblia infection. Neurogastroenterology and Motility. 24: 172-172.
  • Hanevik, Kurt; Dizdar, Vernesa; Langeland, Nina; Eide, Geir Egil; Hausken, Trygve. 2011. Tolerability and effect of mesalazine in postinfectious irritable bowel syndrome. Alimentary Pharmacology and Therapeutics. 34: 259-260. doi: 10.1111/j.1365-2036.2011.04715.x
  • Dizdar, Vernesa; Spiller, Robin; Singh, Gulzar; Hanevik, Kurt; Gilja, Odd Helge; El-Salhy, Magdy; Hausken, Trygve. 2010. Relative importance of abnormalities of CCK and 5-HT (serotonin) in Giardia-induced post-infectious irritable bowel syndrome and functional dyspepsia. Alimentary Pharmacology and Therapeutics. 31: 883-891. doi: 10.1111/j.1365-2036.2010.04251.x
  • El-Salhy, Magdy; Vaali, Kirsi Kaarina; Dizdar, Vernesa; Hausken, Trygve. 2010. Abnormal small-intestinal endocrine cells in patients with irritable bowel syndrome. Digestive Diseases and Sciences. 55: 3508-3513. doi: 10.1007/s10620-010-1169-6
  • Hanevik, Kurt; Dizdar, Vernesa; Langeland, Nina; Hausken, Trygve. 2009. Development of functional gastrointestinal disorders after Giardia lamblia infection. BMC Gastroenterology. 9. doi: 10.1186/1471-230X-9-27
  • Dizdar, Vernesa; Gilja, Odd Helge; Hausken, Trygve. 2007. Increased visceral sensitivity in patients with Giardia-induced Post Infectious FGD. Effect of 5HT3 antagonist onclansetron. Scandinavian Journal of Gastroenterology. 42: 17-17.
  • Dizdar, Vernesa; Gilja, Odd Helge; Hausken, Trygve. 2007. Increased visceral sensitivity in Giardia-induced postinfectious irritable bowel syndrome and functional dyspepsia. Effect of the 5HT(3)-antagonist ondansetron. Neurogastroenterology and Motility. 19: 977-982. doi: 10.1111/j.1365-2982.2007.00988.x

More information in national current research information system (CRIStin)